Related Experiment Video
Updated: Jun 19, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
Antibody response to influenza immunization in coronary artery disease patients: a controlled trial
Maryam Keshtkar-Jahromi1, Hossein Vakili, Mohammad Rahnavardi
1Clinical Research & Development Center, Shahid Modarres Medical Center, Shahid Beheshti University (MC), Tehran, Iran. maryam keshtkar@yahoo.com
Abstract:
Safety of and humoral immune response to the anti-influenza vaccine in coronary artery disease (CAD) patients were evaluated. The trivalent vaccine was administered to 137 eligible CAD patients and 67 age- and sex-matched healthy individuals. Antibody (Ab) titers were measured before and 1 month after vaccination. CAD and HC groups were not significantly different in serologic response and magnitude of change in antibody titers against each of the vaccine antigens. In multivariate analyses, regular exercise and using multivitamin supplements were independently associated with better antibody response among CAD patients. There were no major cardiac or general adverse effects. Influenza vaccine was found safe in CAD patients and antibody responses were similar to HCs.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Cross-reactivity
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations

